Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study
Identifieur interne : 003031 ( Main/Exploration ); précédent : 003030; suivant : 003032Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study
Auteurs : Jaime Kulisevsky [Espagne] ; Berta Pascual-Sedano [Espagne] ; Manel Barbanoj [Espagne] ; Alexandre Gironell [Espagne] ; Javier Pagonabarraga [Espagne] ; Carmen García-Sánchez [Espagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2007-01.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Administration, Oral, Affect (drug effects), Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (blood), Anxiety, Anxiety (drug therapy), Anxiety (etiology), Case-Control Studies, Cross-Over Studies, Dopamine, Double blind study, Double-Blind Method, Female, Humans, Levodopa, Levodopa (administration & dosage), Levodopa (blood), Male, Middle Aged, Mood, Nervous system diseases, Pain Measurement, Parkinson Disease (blood), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson disease, Parkinson's disease, Release, Time Factors, anxiety, dopamine, levodopa, mood.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , blood : Antiparkinson Agents, Levodopa.
- blood : Parkinson Disease.
- drug effects : Affect.
- drug therapy : Anxiety, Parkinson Disease.
- etiology : Anxiety.
- physiopathology : Parkinson Disease.
- Administration, Oral, Aged, Case-Control Studies, Cross-Over Studies, Double-Blind Method, Female, Humans, Male, Middle Aged, Pain Measurement, Time Factors.
Abstract
Mood fluctuations related to levodopa (LD) dosing are well‐known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing‐off) and to different pharmacokinetic profiles of oral LD. We used an intrasubject randomized double‐blind crossover design to study 14 patients (7 stable, 7 wearing‐off) who were monitored for motor status, mood, anxiety, and plasma LD levels 1 hour before and 6 hours after an oral dose of immediate‐release (IR) and controlled‐release LD formulations. Analysis of the dose–response curves showed a significant interaction between the type of motor response and the type of LD. Only the wearing‐off patients had a significant mood elevation, and this effect was only significant following challenge with IR LD. Motor status strongly correlated with LD plasma levels and anxiety but not with mood ratings. Mood changes in PD patients are related to the patient's type of motor response to oral LD and also to the kinetic profile of the LD formulation used for dopaminergic replacement. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.21205
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001C97
- to stream Istex, to step Curation: 001C97
- to stream Istex, to step Checkpoint: 001B39
- to stream PubMed, to step Corpus: 002980
- to stream PubMed, to step Curation: 002980
- to stream PubMed, to step Checkpoint: 002989
- to stream Ncbi, to step Merge: 001959
- to stream Ncbi, to step Curation: 001959
- to stream Ncbi, to step Checkpoint: 001959
- to stream Main, to step Merge: 003F53
- to stream PascalFrancis, to step Corpus: 001834
- to stream PascalFrancis, to step Curation: 001487
- to stream PascalFrancis, to step Checkpoint: 001806
- to stream Main, to step Merge: 004396
- to stream Main, to step Curation: 003031
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study</title><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name></author><author><name sortKey="Pascual Edano, Berta" sort="Pascual Edano, Berta" uniqKey="Pascual Edano B" first="Berta" last="Pascual-Sedano">Berta Pascual-Sedano</name></author><author><name sortKey="Barbanoj, Manel" sort="Barbanoj, Manel" uniqKey="Barbanoj M" first="Manel" last="Barbanoj">Manel Barbanoj</name></author><author><name sortKey="Gironell, Alexandre" sort="Gironell, Alexandre" uniqKey="Gironell A" first="Alexandre" last="Gironell">Alexandre Gironell</name></author><author><name sortKey="Pagonabarraga, Javier" sort="Pagonabarraga, Javier" uniqKey="Pagonabarraga J" first="Javier" last="Pagonabarraga">Javier Pagonabarraga</name></author><author><name sortKey="Garcia Nchez, Carmen" sort="Garcia Nchez, Carmen" uniqKey="Garcia Nchez C" first="Carmen" last="García-Sánchez">Carmen García-Sánchez</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1BB19DABBD4204034AE8EBCF36C1B8E83C9C74C4</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21205</idno><idno type="url">https://api.istex.fr/document/1BB19DABBD4204034AE8EBCF36C1B8E83C9C74C4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001C97</idno><idno type="wicri:Area/Istex/Curation">001C97</idno><idno type="wicri:Area/Istex/Checkpoint">001B39</idno><idno type="wicri:doubleKey">0885-3185:2007:Kulisevsky J:acute:effects:of</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17115388</idno><idno type="wicri:Area/PubMed/Corpus">002980</idno><idno type="wicri:Area/PubMed/Curation">002980</idno><idno type="wicri:Area/PubMed/Checkpoint">002989</idno><idno type="wicri:Area/Ncbi/Merge">001959</idno><idno type="wicri:Area/Ncbi/Curation">001959</idno><idno type="wicri:Area/Ncbi/Checkpoint">001959</idno><idno type="wicri:doubleKey">0885-3185:2007:Kulisevsky J:acute:effects:of</idno><idno type="wicri:Area/Main/Merge">003F53</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:07-0133218</idno><idno type="wicri:Area/PascalFrancis/Corpus">001834</idno><idno type="wicri:Area/PascalFrancis/Curation">001487</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">001806</idno><idno type="wicri:doubleKey">0885-3185:2007:Kulisevsky J:acute:effects:of</idno><idno type="wicri:Area/Main/Merge">004396</idno><idno type="wicri:Area/Main/Curation">003031</idno><idno type="wicri:Area/Main/Exploration">003031</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study</title><author><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Pascual Edano, Berta" sort="Pascual Edano, Berta" uniqKey="Pascual Edano B" first="Berta" last="Pascual-Sedano">Berta Pascual-Sedano</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Barbanoj, Manel" sort="Barbanoj, Manel" uniqKey="Barbanoj M" first="Manel" last="Barbanoj">Manel Barbanoj</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Center for Drug Research, Pharmacology and Therapeutics Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Gironell, Alexandre" sort="Gironell, Alexandre" uniqKey="Gironell A" first="Alexandre" last="Gironell">Alexandre Gironell</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Pagonabarraga, Javier" sort="Pagonabarraga, Javier" uniqKey="Pagonabarraga J" first="Javier" last="Pagonabarraga">Javier Pagonabarraga</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Garcia Nchez, Carmen" sort="Garcia Nchez, Carmen" uniqKey="Garcia Nchez C" first="Carmen" last="García-Sánchez">Carmen García-Sánchez</name><affiliation wicri:level="3"><country xml:lang="fr">Espagne</country><wicri:regionArea>Movement Disorders Unit, Neurology Department, Autonomous University of Barcelona, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-01">2007-01</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="62">62</biblScope><biblScope unit="page" to="67">67</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">1BB19DABBD4204034AE8EBCF36C1B8E83C9C74C4</idno><idno type="DOI">10.1002/mds.21205</idno><idno type="ArticleID">MDS21205</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Affect (drug effects)</term><term>Aged</term><term>Antiparkinson Agents (administration & dosage)</term><term>Antiparkinson Agents (blood)</term><term>Anxiety</term><term>Anxiety (drug therapy)</term><term>Anxiety (etiology)</term><term>Case-Control Studies</term><term>Cross-Over Studies</term><term>Dopamine</term><term>Double blind study</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Levodopa</term><term>Levodopa (administration & dosage)</term><term>Levodopa (blood)</term><term>Male</term><term>Middle Aged</term><term>Mood</term><term>Nervous system diseases</term><term>Pain Measurement</term><term>Parkinson Disease (blood)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Release</term><term>Time Factors</term><term>anxiety</term><term>dopamine</term><term>levodopa</term><term>mood</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Affect</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Anxiety</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anxiety</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Case-Control Studies</term><term>Cross-Over Studies</term><term>Double-Blind Method</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pain Measurement</term><term>Time Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Angoisse anxiété</term><term>Dopamine</term><term>Etude double insu</term><term>Humeur</term><term>Libération</term><term>Lévodopa</term><term>Parkinson maladie</term><term>Système nerveux pathologie</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mood fluctuations related to levodopa (LD) dosing are well‐known psychiatric complications of Parkinson's disease (PD). No formal studies explored how affective response to LD relates to the type of motor response to oral LD (stable or wearing‐off) and to different pharmacokinetic profiles of oral LD. We used an intrasubject randomized double‐blind crossover design to study 14 patients (7 stable, 7 wearing‐off) who were monitored for motor status, mood, anxiety, and plasma LD levels 1 hour before and 6 hours after an oral dose of immediate‐release (IR) and controlled‐release LD formulations. Analysis of the dose–response curves showed a significant interaction between the type of motor response and the type of LD. Only the wearing‐off patients had a significant mood elevation, and this effect was only significant following challenge with IR LD. Motor status strongly correlated with LD plasma levels and anxiety but not with mood ratings. Mood changes in PD patients are related to the patient's type of motor response to oral LD and also to the kinetic profile of the LD formulation used for dopaminergic replacement. © 2006 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Espagne</li></country><region><li>Catalogne</li></region><settlement><li>Barcelone</li></settlement></list><tree><country name="Espagne"><region name="Catalogne"><name sortKey="Kulisevsky, Jaime" sort="Kulisevsky, Jaime" uniqKey="Kulisevsky J" first="Jaime" last="Kulisevsky">Jaime Kulisevsky</name></region><name sortKey="Barbanoj, Manel" sort="Barbanoj, Manel" uniqKey="Barbanoj M" first="Manel" last="Barbanoj">Manel Barbanoj</name><name sortKey="Garcia Nchez, Carmen" sort="Garcia Nchez, Carmen" uniqKey="Garcia Nchez C" first="Carmen" last="García-Sánchez">Carmen García-Sánchez</name><name sortKey="Gironell, Alexandre" sort="Gironell, Alexandre" uniqKey="Gironell A" first="Alexandre" last="Gironell">Alexandre Gironell</name><name sortKey="Pagonabarraga, Javier" sort="Pagonabarraga, Javier" uniqKey="Pagonabarraga J" first="Javier" last="Pagonabarraga">Javier Pagonabarraga</name><name sortKey="Pascual Edano, Berta" sort="Pascual Edano, Berta" uniqKey="Pascual Edano B" first="Berta" last="Pascual-Sedano">Berta Pascual-Sedano</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003031 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003031 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1BB19DABBD4204034AE8EBCF36C1B8E83C9C74C4
|texte= Acute effects of immediate and controlled‐release levodopa on mood in Parkinson's disease: A double‐blind study
}}
| This area was generated with Dilib version V0.6.23. |  |